Summary: Roche will showcase its solutions for “laboratories of the future” at ADLM 2024, demonstrating how its integrated systems and data solutions optimize laboratory resources and enhance health outcomes.

Takeaways:

  1. Advanced Technology Demonstrations: Roche will exhibit its latest generation of cobas solutions, including the cobas Mass Spec solution, cobas liat system, and cobas pure integrated solutions, highlighting their efficiency and integration capabilities.
  2. Digital Innovations: Roche’s navify digital solutions will be presented, showcasing how they securely integrate data across care settings to drive operational, clinical, and financial value.
  3. Enhanced Laboratory Operations: The exhibit will feature systems designed for seamless integration and improved user experiences, such as the cobas 5800 molecular PCR-testing solution and the LightCycler PRO qPCR system, demonstrating Roche’s commitment to advancing laboratory operations and patient outcomes.

Roche will showcase a laboratory of the future exhibit at the 2024 Association for Diagnostics & Laboratory Medicine (ADLM) Scientific Meeting and Clinical Lab Expo, July 28 through August 1, 2024 in Chicago. Attendees will have the opportunity to experience how Roche’s growing portfolio of integrated systems and data solutions optimizes resources and simplifies and streamlines operations while driving better health outcomes. 

“Laboratorians strive to deliver trusted, timely test results to patients with greater effectiveness and efficiency. Our latest generation of cobas solutions are proven to deliver seamless integration of systems and data to support these efforts,” says Brad Moore, president and CEO of Roche Diagnostics North America. “We are excited to share these next-generation solutions, which are the building blocks for future laboratories, and are eager to partner with our customers so that they can both do more with less and deliver the best possible outcomes for patients.”

  • The future cobas Mass Spec solution*, is a total end-to-end solution for clinical mass spectrometry testing with the goal of seamless integration into the routine laboratory.
  • The new CCM Vertical is a flexible modular system that uses lab space effectively and seamlessly integrates into the existing cobas connection modules.
  • The cobas liat system brings gold-standard PCR technology to the point of care, providing results within 20 minutes across a growing menu of assays, now including the cobas liat SARS-CoV-2, Influenza A/B & RSV assay** to test for four common respiratory viruses, all in within one test.
  • The cobas pure integrated solutions combine clinical chemistry, immunoassay and Ion-Selective Electrode (ISE) diagnostic testing on a single platform for low- to mid-volume testing needs.
  • The cobas eplex system, a rapid syndromic molecular diagnostic solution, has been updated with new features across all aspects of the workflow process.
  • The cobas 5800 is a compact, fully automated molecular PCR-testing solution with a comprehensive menu of assays.
  • The LightCycler PRO is a qPCR system designed to deliver accuracy and flexibility to research and clinical diagnostic laboratories with an improved user experience.

Further reading: Roche Launches New Analytical Units for Cobas Pro Integrated Solutions

Roche also will present its full array of navify digital solutions, which securely integrate data across care settings, connecting the healthcare community and accelerating access to innovation and insights. Our digital solutions enable confident healthcare decisions and help you drive operational, clinical and financial value.

References:

*Not currently for sale in the United States.

**This product has not been cleared or approved by the Food and Drug Administration (FDA), but has been authorized for emergency use by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories.